Combined-resisting injection for secondary mixed infection of viral diseases of animals
A technology for viral diseases and mixed infection, applied in the field of combined anti-injection for mixed infection secondary to animal viral diseases, can solve the problems of long treatment time, slow fever reduction, high treatment cost, and achieve the effect of enhancing immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0016] Lianbang injection for mixed infection secondary to viral diseases in animals, characterized in that the main components include Yinhuang extract, trimethoprim, sulfamethoxine sodium, levofloxacin hydrochloride, indomethacin, naproxen, Water for Injection.
[0017] The content of the main components is: silver yellow extract 5%~10%, trimethoprim 4%~8%, sulfamethoxine sodium 4%~8%, levofloxacin hydrochloride 3%~6%, indole Mexicin 5%~10%, Naproxen 4%~8%, Water for Injection 55%~75%.
[0018] The silver yellow extract includes honeysuckle extract and Huangling extract, the contents of which are 9%-16% and 84%-91% respectively.
[0019] According to the above-mentioned technical scheme, the present invention has respectively prepared linked antibody injections with different component contents.
[0020] The first group: Yinhuang extract 10%, trimethoprim 7%, sulfamethoxine sodium 5%, levofloxacin hydrochloride 4%, indomethacin 8%, naproxen 6%, water for injection 60%, Am...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com